1. Home
  2. KRNT vs PHVS Comparison

KRNT vs PHVS Comparison

Compare KRNT & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNT
  • PHVS
  • Stock Information
  • Founded
  • KRNT 2002
  • PHVS 2015
  • Country
  • KRNT Israel
  • PHVS Switzerland
  • Employees
  • KRNT N/A
  • PHVS N/A
  • Industry
  • KRNT Industrial Machinery/Components
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRNT Industrials
  • PHVS Health Care
  • Exchange
  • KRNT Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • KRNT 893.9M
  • PHVS 980.9M
  • IPO Year
  • KRNT 2015
  • PHVS 2021
  • Fundamental
  • Price
  • KRNT $21.48
  • PHVS $23.00
  • Analyst Decision
  • KRNT Strong Buy
  • PHVS Buy
  • Analyst Count
  • KRNT 5
  • PHVS 6
  • Target Price
  • KRNT $33.20
  • PHVS $37.17
  • AVG Volume (30 Days)
  • KRNT 177.3K
  • PHVS 71.6K
  • Earning Date
  • KRNT 08-06-2025
  • PHVS 08-13-2025
  • Dividend Yield
  • KRNT N/A
  • PHVS N/A
  • EPS Growth
  • KRNT N/A
  • PHVS N/A
  • EPS
  • KRNT N/A
  • PHVS N/A
  • Revenue
  • KRNT $206,506,000.00
  • PHVS N/A
  • Revenue This Year
  • KRNT $10.86
  • PHVS N/A
  • Revenue Next Year
  • KRNT $12.68
  • PHVS N/A
  • P/E Ratio
  • KRNT N/A
  • PHVS N/A
  • Revenue Growth
  • KRNT N/A
  • PHVS N/A
  • 52 Week Low
  • KRNT $13.59
  • PHVS $11.51
  • 52 Week High
  • KRNT $34.29
  • PHVS $26.33
  • Technical
  • Relative Strength Index (RSI)
  • KRNT 59.51
  • PHVS 70.21
  • Support Level
  • KRNT $19.72
  • PHVS $21.84
  • Resistance Level
  • KRNT $21.98
  • PHVS $24.41
  • Average True Range (ATR)
  • KRNT 0.68
  • PHVS 1.74
  • MACD
  • KRNT 0.26
  • PHVS 0.54
  • Stochastic Oscillator
  • KRNT 84.44
  • PHVS 76.27

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: